Redesign Science Raises $15M in Seed-2 and Seed-3 Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Page 11 - Refactor Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Refactor Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Refactor Capital Today - Breaking & Trending Today
Redesign Science - AlleyWatch
Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery. Founded by David Rooklin and Haotian Li in 2017, Redesign Science is backed by investors that include Morningside Venture Capital, Notation Capital, Refactor Capital, Third Kind Venture Capital, and Thomas Weingarten and is headquartered in New York.
Source: alleywatch.com
Notable and CicloMed Initiate Phase 1B/2A Clinical Trial of Fosciclopirox in Acute Myelogenous Leuke
Notable Will Leverage Its High-Fidelity Predictive Precision Medicines Platform With The Goal Of Assessing Patient Responsiveness To FosciclopiroxFOSTER CITY, Calif. and KANSAS CITY, Mo.--(BUSINESS WIRE)--#drugdevelopment--Notable Labs, Inc. (Notable), a clinical-stage predictive precision therapeutics company and C...
Source: pharmiweb.com
Notable and CicloMed Initiate Phase 1B/2A Clinical Trial of Fosciclopirox in Acute Myelogenous Leukemia Under Co-Development Agreement
FOSTER CITY, Calif. and KANSAS CITY, Mo.--(BUSINESS WIRE)--Dec 1, 2021--
Source: wsiltv.com
CommonSpirit and Vital Improve Patient Experience in Emergency and Patient Care Delivery
Chicago, IL (PRWEB) October 20, 2021 -- CommonSpirit Health, one of the nation's largest health systems, today announces positive results of its work with
Source: prweb.com